News Daily News Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure Michael O'Riordan December 30, 2025
News Conference News ESC 2025 MAPLE-HCM Is a Win, ODYSSEY-HCM Isn’t: Obstructive vs Nonobstructive Divide Caitlin E. Cox August 30, 2025
News Daily News Mavacamten Strikes Out in Phase III Trial of Nonobstructive HCM L.A. McKeown April 15, 2025
News Features Heart Failure Care Has a Pipeline Problem: What’s the Fix? Shelley Wood December 20, 2022
News Conference News ESC Heart Failure 2022 Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE Todd Neale May 31, 2022
News Features Playing With Heart: Returning Kids Safely to Sport in the COVID-19 Era Todd Neale November 02, 2020
News Conference News TCT 2018 ULTIMATE: IVUS Superior to Angiography at Guiding PCI, With Less TVF by 1 Year Lucy Hicks September 24, 2018